Research programme: hepatocellular carcinoma therapeutics - Enzo BiochemAlternative Names: Leptin - Enzo Biochem
Latest Information Update: 30 Sep 2009
At a glance
- Originator Enzo Biochem
- Class Intracellular signalling peptides and proteins; Peptide hormones
- Mechanism of Action Natural killer cell stimulants
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued Hepatocellular carcinoma
Most Recent Events
- 30 Sep 2009 Discontinued - Preclinical for Hepatocellular carcinoma in USA (unspecified route)
- 11 Jul 2005 Preclinical trials in Hepatocellular carcinoma in USA (unspecified route)